A first-in-human phase Ia clinical trial of NDX-1017

Trial Profile

A first-in-human phase Ia clinical trial of NDX-1017

Planning
Phase of Trial: Phase I

Latest Information Update: 19 Apr 2017

At a glance

  • Drugs NDX 1017 (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 19 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top